LBEL

Product NDC: 14783-990
11-digit product format: 147830990
Labeler code: 14783
Product ID: 14783-990_c55866be-7df4-4214-b7c5-3cb3de98d9f2
Type: HUMAN OTC DRUG
Nonproprietary name: OCTINOXATE and OXYBENZONE
Dosage form: LIPSTICK
Route: TOPICAL
Labeler: Ventura International, Limited
Application: part352
Marketing category: OTC MONOGRAPH NOT FINAL
Marketing start: 2010-11-26
Marketing end: 0000-00-00
Substance: OCTINOXATE; OXYBENZONE
Active strength: 0 g/g; g/g
NDC exclude flag: E
Listing certified through: 2017-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	14783-990		D	Discontinued by firm	2026-10-12
excluded package	package	14783-990	14783-990-05	D	Discontinued by firm	2026-10-12
excluded package	package	14783-990	14783-990-12	D	Discontinued by firm	2026-10-12

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 2 · 66 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	14783-990-12	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	14783-990-05	D	Discontinued by firm	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	14783-990-12	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	14783-990-05	D	Discontinued by firm	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	14783-990-05	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	14783-990-12	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	14783-990-05	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	14783-990-12	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	14783-990-05	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	14783-990-12	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	14783-990-05	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	14783-990-12	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	14783-990-05	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	14783-990-12	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	14783-990-05	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	14783-990-12	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	14783-990-05	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	14783-990-12	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	14783-990-05	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	14783-990-12	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	14783-990-05	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	14783-990-12	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	14783-990-05	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	14783-990-12	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	14783-990-05	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	14783-990-12	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	14783-990-05	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	14783-990-12	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	14783-990-05	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	14783-990-12	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	14783-990-12	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	14783-990-05	I	Inactivated by FDA	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded product	product		I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	14783-990-12	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-09 23:13 UTC · source 2022-04-08	excluded package	package	14783-990-05	I	Inactivated by FDA	`86f5da6cb304…`	`a595104c45d7…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded product	product		I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	14783-990-12	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2022-04-04 05:40 UTC · source 2022-04-01	excluded package	package	14783-990-05	I	Inactivated by FDA	`bd6a592717d7…`	`303034d00443…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded product	product		I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	14783-990-12	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2021-12-27 23:28 UTC · source 2021-12-27	excluded package	package	14783-990-05	I	Inactivated by FDA	`8dfbde2a14a4…`	`c9ff85d89658…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded product	product		I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	14783-990-12	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`
2020-12-18 03:04 UTC · source 2020-12-17	excluded package	package	14783-990-05	I	Inactivated by FDA	`e2bbac7714bc…`	`27bdfed8d636…`

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Related label table
NDC	Effective	Related label
14783-990-05	2025-03-31	L'BEL COULEUR LUXE ROUGE IRRÉSISTIBLE maximum hydration lipstick SPF 17
14783-990-12	2025-03-31	L'BEL COULEUR LUXE ROUGE IRRÉSISTIBLE maximum hydration lipstick SPF 17
14783-990-05	2019-10-29	L'BEL COULEUR LUXE ROUGE IRRÉSISTIBLE maximum hydration lipstick SPF 17
14783-990-12	2019-10-29	L'BEL COULEUR LUXE ROUGE IRRÉSISTIBLE maximum hydration lipstick SPF 17

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
Ingredient	Type	UNII	DailyMed label	SPL version
OCTINOXATE	ACTIVE INGREDIENT	4Y5P7MUD51	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
OXYBENZONE	ACTIVE INGREDIENT	95OOS7VE0Y	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
OCTINOXATE	ACTIVE MOIETY	4Y5P7MUD51	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
OXYBENZONE	ACTIVE MOIETY	95OOS7VE0Y	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
ALOE VERA LEAF	INACTIVE INGREDIENT	ZY81Z83H0X	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
ALUMINUM OXIDE	INACTIVE INGREDIENT	LMI26O6933	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
BISMUTH OXYCHLORIDE	INACTIVE INGREDIENT	4ZR792I587	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
BUTYLATED HYDROXYANISOLE	INACTIVE INGREDIENT	REK4960K2U	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
BUTYLATED HYDROXYTOLUENE	INACTIVE INGREDIENT	1P9D0Z171K	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
BUTYLPARABEN	INACTIVE INGREDIENT	3QPI1U3FV8	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
CANDELILLA WAX	INACTIVE INGREDIENT	WL0328HX19	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
CARNAUBA WAX	INACTIVE INGREDIENT	R12CBM0EIZ	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
CERESIN	INACTIVE INGREDIENT	Q1LS2UJO3A	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
CETEARYL GLUCOSIDE	INACTIVE INGREDIENT	09FUA47KNA	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
CETOSTEARYL ALCOHOL	INACTIVE INGREDIENT	2DMT128M1S	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
CHOLESTEROL	INACTIVE INGREDIENT	97C5T2UQ7J	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
D&C BLUE NO. 4	INACTIVE INGREDIENT	0KSY80VYS3	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
D&C RED NO. 21	INACTIVE INGREDIENT	08744Z6JNY	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
D&C RED NO. 30	INACTIVE INGREDIENT	2S42T2808B	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
D&C RED NO. 7	INACTIVE INGREDIENT	ECW0LZ41X8	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
ETHYLHEXYL PALMITATE	INACTIVE INGREDIENT	2865993309	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
ETHYLPARABEN	INACTIVE INGREDIENT	14255EXE39	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
FD&C BLUE NO. 1	INACTIVE INGREDIENT	H3R47K3TBD	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
FD&C RED NO. 40	INACTIVE INGREDIENT	WZB9127XOA	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
FD&C YELLOW NO. 5	INACTIVE INGREDIENT	I753WB2F1M	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
FERRIC OXIDE RED	INACTIVE INGREDIENT	1K09F3G675	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
FERRIC OXIDE YELLOW	INACTIVE INGREDIENT	EX438O2MRT	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
ISOBUTYLPARABEN	INACTIVE INGREDIENT	0QQJ25X58G	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
MEDIUM-CHAIN TRIGLYCERIDES	INACTIVE INGREDIENT	C9H2L21V7U	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
METHYLPARABEN	INACTIVE INGREDIENT	A2I8C7HI9T	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
MICA	INACTIVE INGREDIENT	V8A1AW0880	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
MICROCRYSTALLINE WAX	INACTIVE INGREDIENT	XOF597Q3KY	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
OCTYLDODECANOL	INACTIVE INGREDIENT	461N1O614Y	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
PALMITIC ACID	INACTIVE INGREDIENT	2V16EO95H1	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
PETROLATUM	INACTIVE INGREDIENT	4T6H12BN9U	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
PHENOXYETHANOL	INACTIVE INGREDIENT	HIE492ZZ3T	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
PROPYLENE CARBONATE	INACTIVE INGREDIENT	8D08K3S51E	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
PROPYLPARABEN	INACTIVE INGREDIENT	Z8IX2SC1OH	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
SHEA BUTTER	INACTIVE INGREDIENT	K49155WL9Y	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
SILICON DIOXIDE	INACTIVE INGREDIENT	ETJ7Z6XBU4	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
TALC	INACTIVE INGREDIENT	7SEV7J4R1U	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
TITANIUM DIOXIDE	INACTIVE INGREDIENT	15FIX9V2JP	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
TRIDECYL STEARATE	INACTIVE INGREDIENT	A8OE252M6L	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1
YELLOW WAX	INACTIVE INGREDIENT	2ZA36H0S2V	LBEL (OCTINOXATE AND OXYBENZONE) LIPSTICK [VENTURA INTERNATIONAL, LIMITED]	1

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
4Y5P7MUD51	OCTINOXATE	83834-59-7	OCTINOXATE
95OOS7VE0Y	OXYBENZONE	131-57-7	OXYBENZONE

Title, Manufacturer, Effective date table
Title	Manufacturer	Effective date	Type	Version
L'BEL COULEUR LUXE ROUGE IRRÉSISTIBLE maximum hydration lipstick SPF 17	Ventura International, Limited \| BelStar, S.A.	2010-11-10	HUMAN OTC DRUG LABEL	1

LBEL

NDC auxiliary status#

Observed NDC auxiliary status history#

Reported adverse events (FAERS/openFDA)#

FDA-Initiated Inactive NDC Indexing#

DailyMed Socrata Ingredients#

Related Records#

Related UNII Ingredients#

Related DailyMed Labels#